ARTICLE | Distillery Therapeutics
Cancer
November 6, 2018 8:46 PM UTC
Patient sample and mouse studies suggest promoting expression of IRF9 and STAT2 could help treat clear cell renal cell carcinoma (ccRCC). In patients, low levels of IRF9 in tumor samples were associat...